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Abstract
Objective—Measles–mumps–rubella (MMR) vaccination is important for preventing disease 
outbreaks, yet pockets of under-vaccination persist. Text message reminders have been employed 
successfully for other pediatric vaccines, but studies examining their use for MMR vaccination are 
limited. This study assessed the impact of text message reminders on timely MMR vaccination.
Study design—Parents (n = 2054) of 9.5–10.5-month-old children from four urban 
academically-affiliated pediatric clinics were randomized to scheduling plus appointment text 
message reminders, appointment text message reminder-only, or usual care. The former included 
up to three text reminders to schedule the one-year preventive care visit. Both text messaging arms 
included a text reminder sent 2 days before that visit. Outcomes included appointment scheduling, 
appointment attendance, and MMR vaccination by age 13 months, the standard of care at study 
sites.
Results—Children of parents in the scheduling plus appointment text message reminders arm 
were more likely to have a scheduled one-year visit than those in the other arms (71.9% vs. 67.4%, 
relative risk ratio (RRR) 1.07 [95% CI 1.005–1.13]), particularly if no appointment was scheduled 
before randomization (i.e., no baseline appointment) (62.1% vs. 54.7%, RRR 1.14 [95% CI 1.04–
1.24]). One-year visit attendance and timely MMR vaccination were similar between arms. 
☆Trial Registration Number: NCT01199666.
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However, among children without a baseline appointment, those with parents in the scheduling 
plus appointment text message reminders arm were more likely to undergo timely MMR 
vaccination (61.1% vs. 55.1%, RRR 1.11 [95% CI 1.01–1.21]).
Conclusion—Text message reminders improved timely MMR vaccination of high-risk children 
without a baseline one-year visit.
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1. Introduction
Measles was officially eliminated, defined as interruption of year-round endemic measles 
transmission, in the United States in 2000 [1,2]. However, measles outbreaks continue to 
occur. In 2014, the highest number of measles cases (644) was reported since its elimination 
in 2000 [3]. In January–February 2015, there were 154 cases stemming primarily from one 
multi-state outbreak [3]. Most cases resulted from importation from endemic areas world-
wide, either by U.S. or foreign travellers, and occurred in individuals who were unvaccinated 
or had unknown vaccination status [4]. Although the racial/ethnic disparities in measles 
vaccination coverage that contributed to significant outbreaks in 1989 and 1990 no longer 
exist for children 19–35 months of age [5,6], low-income and minority children are at risk 
for less timely vaccination overall [7].
The Advisory Committee on Immunization Practices (ACIP) currently recommends routine 
measles–mumps–rubella (MMR) vaccination at age 12–15 months and booster vaccination 
at age 4–6 years [2]. The vaccine is highly effective when administered as recommended, 
with a median two-dose effectiveness of 97% [2]. National Immunization Survey (NIS) data 
indicate that approximately 92% of 19–35-month-olds have received their first MMR 
vaccine dose [8], in line with Healthy People 2020 coverage goals [9]. Nonetheless, pockets 
of under-immunization continue to exist, including in 17 states with coverage below the 90% 
target level [8]. Further, 1 in 12 U.S. children have delayed receipt of their first dose, 
increasing their susceptibility to measles infection [8]. The reasons for this under- and 
delayed immunization are unclear. Some families may have difficulty remembering to 
schedule an appointment for the one-year preventive care visit during which the MMR 
vaccine and other primary care services are routinely offered, while others may not 
remember to attend the appointment. Such pragmatic barriers for early childhood vaccines 
have been demonstrated among low-income minority families [10]. Missed opportunities for 
MMR vaccination or parental refusal of MMR vaccine at these visits are other possible 
explanations [11].
Text message vaccine reminder/recall is one promising strategy for reaching families, 
particularly of low-income minority children. Previous studies have shown that most parents 
of such children have text message-enabled cell phones (88–89%) and are interested in 
receiving text message appointment reminders (81%) and vaccine reminders (96–100%) 
[12,13]. Studies have demonstrated the effectiveness of text messaging for improving 
coverage levels for needed vaccines such as Haemophilus influenzae type b (Hib), human 
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papillomavirus, meningococcal, and tetanus–diphtheria–acellular pertussis, and influenza 
among low-income minority children and adolescents [14–16]. A pilot study (n = 90) of text 
message reminders for sentinel infant vaccines also showed promise, although findings were 
not significant, likely due to limited power [17]. The impact of text message reminders on 
MMR vaccination has yet to be determined.
The primary aim of this study was to examine the effect of text message reminders on timely 
MMR vaccination – defined here as vaccination by 13 months of age – among low-income 
minority children from a community in New York City where one of the first measles 
outbreaks of 2014 occurred. A secondary aim was to assess the impact of text message 
reminders on the scheduling of and attendance at the one-year preventive care visit. We 
hypothesized that text message reminders would improve timely receipt of MMR 
vaccination, in part due to increased scheduling of and attendance at one-year preventive 
care visits.
2. Methods
2.1. Study design
This randomized controlled trial examined the impact of text message reminders on timely 
MMR vaccination as well as scheduling of and attendance at the one-year preventive care 
visit. The study was approved by the Columbia University Medical Center Institutional 
Review Board with a waiver of consent.
2.2. Setting
This study was conducted in four pediatric practices in an ambulatory care network affiliated 
with a large academic medical center. At these sites, the standard of care was to administer 
the first routine MMR vaccine dose at the one-year preventive care visit based upon a history 
of measles outbreaks in New York City and frequent international travel by community 
residents. The vast majority of patients were eligible to receive free vaccines through the 
VFC Program.
2.3. Population
Parents were eligible for participation if their child (1) was age 9.5–10.5 months, (2) had a 
participating clinic visit in the past 6 months, and (3) had a cellular phone number listed in 
the hospital registration system. If there were twins or triplets, only one child was randomly 
selected for analysis; text messages pertaining to the twin or triplet siblings were also sent to 
parents in the text messaging arms to avoid potential confusion.
2.4. Data sources
This study utilized a customized text messaging platform integrated with the hospital 
registration system and its immunization registry, EzVac. The registration system included 
demographic and visit data for subjects, while the EzVac registry automatically captured 
from the institution’s electronic health record all vaccine doses administered to subjects at 
the hospital and affiliated clinics [18]. There was also bidirectional exchange of vaccine data 
between EzVac and the New York City Immunization Registry (CIR). Of note, the CIR was 
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one of the first immunization information systems (IIS) to offer this bidirectional exchange 
and remains at the forefront of IIS functionality. Moreover, New York City providers are 
required to report to the CIR any vaccine administrations to children under age 19 years 
[19]. It is estimated that 94% of facilities vaccinating children regularly do so [20]. Thus, 
vaccine administration data in the present study included MMR vaccine doses administered 
at study sites and non-study sites in New York City.
2.5. Study procedures
There were 2333 children who fulfilled age and visit eligibility criteria (Fig. 1). Of these, 
237 did not have a parental cellular phone number recorded in the registration system and 42 
were twin or triplet siblings; these were excluded from the study. Parents of the remaining 
2054 eligible children were stratified by their child’s clinic site. Using a random sample 
algorithm generator in SPSS 19.0, they were then randomized in monthly intervals between 
June 2011 and October 2012 with a 1:1:1 allocation to receive (1) up to three text message 
reminders to schedule an appointment plus an appointment text message reminder 
(“scheduling plus appointment text message reminders” arm), (2) an appointment text 
message reminder only (“appointment text message reminder-only” arm), or (3) usual care 
(“usual care” arm). With this sample size (n = 2054), randomized with equal allocation, and 
an estimated baseline coverage of 51%, there was 80% power to detect a 7.5% difference in 
MMR vaccination by age 13 months between groups, allowing for a 5% type I error. Study 
analysts were blinded to group assignments.
Immediately following randomization, parents in the scheduling plus appointment text 
message reminders arm received up to three automated weekly text message reminders to 
schedule the one-year appointment; parents in the other arms did not receive reminders to 
schedule an appointment (Fig. 2). The text messages, sent in either English or Spanish 
depending on the primary language specified in the electronic health record, included the 
clinic contact information and mentioned the child’s need for important vaccines like 
measles following the first birthday. They also included the option to switch the language or 
“stop” future messages. If the child already had a scheduled one-year appointment before 
the start of the intervention (i.e., date of the first scheduling reminder), the parent was not 
sent any scheduling reminders unless that appointment was scheduled to occur before 361 
days of age (i.e., outside the grace period for MMR vaccination). Once the intervention was 
initiated, any newly scheduled appointment after 11 months of age was deemed acceptable 
given the possibility of “early” (i.e., between 11 months and 361 days of age) scheduling by 
office staff, and no subsequent scheduling reminders were sent.
Next, parents in both text messaging arms (scheduling plus appointment text message 
reminders and appointment text message reminder-only) received one automated text 
message two days before a scheduled one-year appointment, reminding them about the 
appointment, letting them know that the doctor would discuss needed vaccines, and asking 
them to remember to bring the child’s vaccination card. The reminder was not sent if the 
child had already received MMR vaccine (unless given before 361 days of age). Those in the 
usual care arm received no text message reminders.
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Children in all arms received “usual care”, which included a routine automated telephone 
appointment reminder provided directly from the clinic network. A post-intervention text 
message was sent to parents who received ≥1 text message to assess their satisfaction with 
the reminders.
2.6. Measures
The pre-specified primary outcome measure was MMR vaccination by 13 months of age. 
Doses received up to 4 days before the child’s first birthday were accepted [21]. Doses 
received earlier, e.g., due to international travel, were not accepted. Secondary outcome 
measures were (1) a scheduled one-year appointment between 11 and 13 months of age; (2) 
attendance at the one-year appointment between 11 and 13 months of age; and (3) MMR 
vaccination by 16 months of age.
2.7. Analysis
All analyses used the individual child as the unit of analysis. MMR vaccination by age 13 
months was compared between the three arms using Pearson’s chi-squared test. One-year 
visit scheduling and attendance as well as MMR vaccination by age 16 months were 
similarly compared between arms. Differences and relative risks along with their associated 
95% confidence intervals were calculated. Multivariable logistic regression was used to 
examine interactions between intervention arm and facility. Sub-analyses were conducted 
among those without a baseline one-year appointment (i.e., an appointment between 11 and 
13 months of age that was scheduled before randomization). Additionally, a sensitivity 
analysis comparing appointment attendance between those with vs. without a delivered 
appointment reminder was performed. Analyses were performed using SAS Version 9.3 
(Cary, NC).
3. Results
Of the children of randomized parents (n = 2054), most were publicly insured and had a 
primary language of Spanish (Table 1). Demographic characteristics were similar between 
arms. Two-thirds (68.9%, n = 1415) had a one-year appointment scheduled to occur between 
11 and 13 months. Approximately, one-quarter had this appointment scheduled before 
randomization (26.5% scheduling plus appointment reminders arm; 30.2% appointment 
reminder-only arm; 28.3% usual care arm; p = 0.33); the remaining 1472 children did not 
have a baseline one-year appointment. Children of parents randomized to receive an 
appointment scheduling reminder were more likely to have a scheduled one-year 
appointment than those of parents in the two other arms, particularly if they had no baseline 
appointment (Table 2). In a multivariable model assessing appointment scheduling, there 
was no interaction between intervention arm and facility.
Of children with a scheduled appointment by 13 months of age (n = 1415), appointment 
attendance did not differ between arms (77.9%, p = 0.46) (Table 2). However, there were 78 
children in the text messaging arms whose parents did not receive a text message 
appointment reminder for their scheduled appointment (52 had undeliverable message(s), 4 
requested to stop messaging, 6 had received MMR vaccine before the appointment, and 16 
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for other reasons). When comparing children whose parents had a delivered text message 
appointment reminder vs. those who either did not have a delivered message or were in the 
usual care arm, a significant difference in appointment attendance existed (79.8% vs. 74.8%; 
relative risk ratio (RRR) 1.07 [95% CI 1.00–1.13]). In a multivariable model assessing 
appointment attendance, there was no interaction between intervention arm and facility. 
Overall, a small proportion of subjects either canceled (1.6%) or rescheduled (2.5%) their 
appointment within 48 h before their scheduled visit. Very few appointments (1.1%) were 
canceled >48 h before their scheduled visit and not rescheduled. These outcomes did not 
vary by arm.
Among children of randomized parents (n = 2054), there was no significant difference in 
MMR vaccination by 13 months between arms (62.2%, p = 0.30; Table 2). However, among 
children without a baseline appointment (n = 1472), those in the scheduling plus 
appointment reminders arm were more likely to receive MMR vaccine by 13 months than 
those in the other arms. In a multivariable model assessing MMR vaccination by 13 months, 
there was no interaction between intervention arm and facility. Among those who attended 
their one-year appointment by 13 months (n = 1102), 89.2% received MMR vaccine by 13 
months. Of those who were not vaccinated at that visit (n = 119), 82 were ineligible since 
the appointment occurred before 361 days of age. The remaining 37 were eligible by age to 
receive their MMR vaccine, but were not given this dose for a variety of reasons, including 
febrile illness, perceived contraindications, and provider decision to preferentially administer 
other needed vaccines at that visit. The parents of three of these children deferred/declined 
MMR vaccination. There was no difference in MMR vaccination by 16 months between 
arms (86.0%, p = 0.99).
Of parents in the text messaging arms who were sent ≥1 text message (n = 1254), 0.8% 
elected to “stop” subsequent messages and 7.1% experienced ≥1 undeliverable message. Of 
those sent a follow-up text message assessing satisfaction (n = 1213); 16.9% (n = 205) 
replied: 86.8% reported that they liked the messages, 3.9% thought they were “so-so”, and 
9.3% did not like them.
4. Discussion
In this study, text message reminders increased MMR vaccination coverage, but only among 
high-risk children lacking a scheduled one-year appointment at the beginning of the study 
period. These findings illustrate a potential target population that may benefit most from 
reminders to schedule and attend the one-year preventive care visit, particularly since the 
vast majority of children who came to this appointment received MMR vaccine. Considering 
the 644 reported measles cases from 27 states in 2014 – including one outbreak centered in 
the community in which this study took place – and the 154 reported cases in January–
February 2015, interventions to promote timely MMR vaccination are needed [3]. 
Optimizing protection against measles may be particularly important for urban minority 
populations at potentially increased risk of measles infection and related complications [5].
It is worthwhile noting other potential benefits of timely MMR vaccination. A recent study 
found that MMR vaccine administration before 15 months of age reduced hospitalizations 
Hofstetter et al. Page 6
Vaccine. Author manuscript; available in PMC 2018 March 22.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
for any infection between 16 and 24 months of age, with 201 children needing to receive 
their first MMR vaccine dose by 15 months to prevent one hospitalization [22]. Another 
investigation observed a reduction in fever and seizure risk following MMR vaccination 
when administered early (12–15 months) compared to late (16–23 months) [23]. Conversely, 
some data suggest that MMR vaccine effectiveness may be enhanced when administered 
later (i.e., on/after 15 months of age) [24–26]. Thus, while routine MMR vaccination should 
occur within the 12–15 month age range, text message reminders may be adapted to promote 
best practices in diverse settings with variable infection risk.
In this study, an important effect of the text message reminders was to increase scheduling of 
the one-year preventive care visit. The reminders not only may have served as a “cue to 
action” for parents with competing priorities, but also may have facilitated scheduling by 
including the clinic telephone number and suggesting a visit time frame. Our recent study 
found that nearly half (44%) of urban low-income minority parents, like those included in 
this current study, reported obstacles to scheduling appointments, and this was associated 
with a higher likelihood of missing an immunization visit [10]. Our study observed a greater 
impact of the scheduling text message reminders among the higher risk children who lacked 
a baseline scheduled one-year appointment.
Children of parents with a delivered text message appointment reminder were more likely to 
attend that appointment than children of parents who did not receive the reminder. We 
recently found that, among parents of children with a missed vaccine appointment, 
approximately 21% forgot their child’s appointment [10]. Thus, a text reminder may serve as 
a valuable prompt for parents to attend their child’s appointment. A recent meta-analysis of 
studies among adults concluded that text message appointment reminders have a positive 
impact on attendance that is equivalent to telephone reminders and potentially better than 
written or no appointment reminders; they are also more cost-effective than other reminder 
types [27]. Further examination in the pediatric setting is needed.
In this study, the vast majority of children who scheduled and attended their one-year 
appointment received MMR vaccine during that visit. There were a small number of missed 
vaccination opportunities, which could be minimized through greater provider education, 
e.g., related to appropriate vaccine contraindications. Very few of the study’s predominantly 
low-income, minority, Spanish-speaking parents refused/declined MMR vaccination. This 
finding is consistent with 2010–2013 NIS data showing that three-quarters of children 
unvaccinated against measles had missed being vaccinated for reasons other than negative 
vaccine-related beliefs [11]. These findings differ from those described elsewhere. For 
example, among the unvaccinated U.S. residents who acquired measles in 2013, 79% had 
declined MMR vaccine for philosophical reasons [28]. Similar findings were reported in the 
recent California outbreak [29]. Certainly, parental misperceptions about the MMR vaccine 
could underlie these beliefs. Thus, strategies should be employed to address these other 
concerns in communities where such barriers may be more prevalent. Text messages could 
incorporate educational information about MMR vaccine importance, effectiveness, and 
safety [14,16] – potentially using embedded links or interactive features to provide 
additional information [15–18] – to prime parents for a discussion with their child’s 
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providers. Other studies have shown that the use of leaflets, parent meetings, and decision 
aids may also promote MMR vaccine uptake [30,31].
There are limitations to this study. First, although this study aimed to include active patients 
at the four participating clinics, some children may have transferred care elsewhere during 
the study period. We observed that 320 children (15.6% of the randomized population) never 
had a clinic visit on or after their first birthday. This could have lessened the intervention 
impact, particularly with respect to appointment outcomes that could not be captured using 
the data available. Second, despite their best efforts, parents may have encountered 
unforeseen scheduling difficulties, i.e., too early (<361 days of age) or too late (>13 months 
of age). However, there is no evidence that such scheduling obstacles would not have 
differed by study arm. Finally, this study was conducted in one ambulatory care network 
serving predominantly low-income, minority, Spanish-speaking families; thus, its findings 
may not be generalizable to other clinic settings and/or poulations.
5. Conclusion
This study illustrates the impact of text message reminders on scheduling and attending 
preventive care visits for MMR vaccination. It is also worth noting the potential to capitalize 
on existing text message vaccine reminder/recall systems to promote wide-spread MMR 
vaccination during community outbreak situations such as those in New York City and 
elsewhere in 2014.
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Fig. 1. 
Schematic of study population.
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Fig. 2. 
Overview of study procedures.
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Table 1
Characteristics of study population.
Scheduling + appointment text
message reminders
Appointment text message
reminder-only
Usual care p Value
Total, n 686 686 682
  Gender, % (n) 0.88
  Female 49.4 (339) 48.1 (330) 49.0 (334)
  Male 50.6 (347) 51.9 (356) 51.0 (348)
Language, % (n) 0.43
  Spanish 59.8 (410) 58.2 (399) 57.5 (392)
  English 37.4 (257) 37.3 (256) 39.6 (270)
  Other 1.3 (9) 2.8 (19) 1.5 (10)
  Unknown 1.5 (10) 1.7 (12) 1.4 (10)
Insurance, % (n) 0.72
  Public 82.9 (569) 84.0 (576) 84.5 (576)
  Private 3.4 (23) 4.2 (29) 3.5 (24)
  Uninsured 13.7 (94) 11.8 (81) 12.0 (82)
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